News Eli Lilly and Company Deutsche Boerse AG

Equities

Real-time Estimate Tradegate Other stock markets 10:10:25 2024-05-02 am EDT			5-day change	1st Jan Change
719.5 ^EUR	-1.02%		+3.69%	+36.54%

02:24pm	Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1	RE
07:42am	Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast	RE

Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1	08:24am	RE
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast	01:42am	RE
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast	01:32am	RE
British pharmacies vie for weight-loss patients with drug price cuts	01:03am	RE
Amgen investors await weight-loss drug data	May. 01	RE
Danish Medicines Agency Says Type 2 Diabetes Patients Should Start Treatment With 'Cheaper' Drugs	May. 01	MT
JPMorgan Adjusts Price Target on Eli Lilly to $900 From $850	May. 01	MT
Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813	May. 01	MT
Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810	May. 01	MT
BMO Capital Adjusts Eli Lilly Price Target to $1,001 From $900	May. 01	MT
Leerink Partners Adjusts Price Target on Eli Lilly to $901 From $821	May. 01	MT
Deutsche Bank Adjusts Price Target on Eli Lilly to $725 From $695	May. 01	MT
Truist Raises Price Target on Eli Lilly to $892 From $850, Keeps Buy Rating	May. 01	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723	May. 01	MT
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825	May. 01	MT
Amgen investors await weight-loss drug data	May. 01	RE
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating	May. 01	MT
Equity Markets Drop Ahead of Fed Rate Decision	Apr. 30	MT
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024	Apr. 30	AQ
US Equity Markets Close Down Tuesday After Higher Wage Data	Apr. 30	MT

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT